PDPL

Promoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 and Regulation 31(4) of SEBI SAST Regulations 2011 as on March 31, 2021

Parenteral Drugs (India) Limited hereby submits clippings of Newspaper Publication of Unaudited Financial Results for the Quarter ended on 31st December, 2020, pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on February 12, 2021.

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication for the meeting of board of directors to consider financial results for the third quarter of the FY 2020-21 pursuant to Regulation 30 & 47 of SEBI (LODR) Regulations, 2015

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions on consolidated basis for the half year ending on 30th September, 2020

Parenteral Drugs (India) Limited hereby submits clippings of Newspaper Publication of Unaudited Financial Results for the Quarter and half year ended on 30th September, 2020.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding outcome of Board meeting held on November 10, 2020

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication regarding notice of Board Meeting

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to results of remote e-voting and voting at the 36th Annual General Meeting held on 19th September, 2020 already submitted

Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to Scrutinizer Report of 36th Annual General Meeting held on 19th September, 2020 already submitted

Parenteral Drugs (India) Limited has informed the Exchange regarding reappointment of Mr. Manish Verma, Independent Director for a period of Second Term

Parenteral Drugs (India) Limited has informed the Exchange regarding reappointment of Mr. Govind Das Garg

Parenteral Drugs (India) Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 19, 2020

Parenteral Drugs (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 19, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 19, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 19, 2020 - Intimation of notice sent to shareholders in pursuant to Regulation 30 of SEBI (LODR) Regulation , 2015.

Parenteral Drugs (India) Limited has informed the Exchange about Newspaper Publication regarding Notice of 36th Annual General Meeting.

Parenteral Drugs (India) Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 14-Sep-2020 to 19-Sep-2020 for the purpose of Annual General Meeting.

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Intimation regarding Book Closure .'.from 14th September 2020 to 19th September 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 19, 2020

Parenteral Drugs (India) Limited has informed the Exchange about disclosure of Related Party Transactions on consolidated basis for the half year ended on 31st March, 2020

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of public notice of 36th Annual General Meeting.

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper clippings for Unaudited financial results for the quarter ended 30th June 2020 published pursuant to Regulation of 47 SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Limited Review Report for the Quarter ended Jun 30, 2020

Parenteral Drugs (India ) Limited hereby submits Quarterly Unaudited Financial Results (on both Standalone and Consolidated basis) of the Company for the financial year 2020-21 ended on 30th June, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 25, 2020.

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Annual Audited Financial Results for the quarter and year ended on 31st March, 2020 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on July 29, 2020.

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Announcement under Regulation 30 (LODR)- Newspaper Publication regarding Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015'.

Parenteral Drugs (India) Limited has submitted to the Exchange Annual Disclosure as per SEBI Circular dated November 26, 2018.

Parenteral Drugs (India) Limited has informed the Exchange regarding ' Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2020'.

Promoters of Parenteral Drugs (India) Limited has informed the Exchange regarding the disclosure pursuant to the provisions of Regulation 30 & 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as at 31st March, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding Corrigendum to intimation submitted w.r.t. Acceptance of One Time Loan Settlement proposal on 25th April, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Announcement under Regulation 30 with respect to One time settlement'.

Parenteral Drugs (India) Limited has submitted to the Exchange a copy of newspaper clippings of un-audited financial results for the quarter ended December 31, 2019 published pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

Parenteral Drugs (India) Limited hereby submits Outcome of Board meeting held on February 12, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Announcement under Regulation 30 (LODR)-Newspaper Publication regarding Clippings of Newspaper Notice published pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015'.

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Certificate for quarter ended 31st December, 2019 pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 .'.

Parenteral Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Parenteral Drugs (India) Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019.

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.